We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Tm Bioscience to Supply PathGroup with Tag-It™ Reagents

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Tm Bioscience Corporation has announced it has signed an agreement to supply PathGroup (Brentwood, Tennessee) with the Tag-It™ ASRx reagents for use in its Cystic Fibrosis gene assay.

“We are committed to providing the highest quality medical diagnostic services available, serving patients across Tennessee, Kentucky, Indiana, Illinois, North Carolina, and Georgia,” said Dr. Safedin Beqaj, Laboratory Director, Microbiology and Molecular Diagnostics, PathGroup Labs.

“Using the reagents from Tm Bioscience, we have developed an upgraded CF assay that performs to our high standards and reduces operator time significantly, which will enable PathGroup to address the growing demand for Cystic Fibrosis screening and best serve our customers.”

“We are pleased that PathGroup, a leading provider of diagnostics services for the southeast and lower midwest United States, has selected products from Tm Bioscience and adopted our standardized Tag-It™ approach,” said Greg Hines, President and CEO of Tm Bioscience.

“We look forward to working with Dr. Beqaj to evaluate additional products from our menu.”